Signaling via MYD88 in the pancreatic tumor microenvironment A double-edged sword

被引：14
|
作者：
Zambirinis, Constantinos P. [1 ]
Miller, George [1 ,2 ]
机构：
[1] NYU, Dept Surg, S Arthur Localio Lab, Sch Med, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA
来源：
ONCOIMMUNOLOGY | 2013年 / 2卷 / 01期
关键词：
cancer-associated inflammation; dendritic cells; innate immunity; MYD88; pancreatic cancer; pattern-recognition receptors; Toll-like receptors; tumor microenvironment; NEGATIVE REGULATION;
D O I：
10.4161/onci.22567
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We have recently shown that Toll-like receptor (TLR) signaling exacerbates pancreatic fibro-inflammation and promotes carcinogenesis in mice. Paradoxically, inhibition of the TLR-MYD88 signaling pathway is pro-tumorigenic owing to the dendritic cell-mediated T(H)2-polarization of CD4(+) T cells. TLR signaling appears to be central in pancreatic cancer-associated inflammation.
引用
收藏
页数：3
相关论文
共 50 条
  • [41] NKT cells and tumor immunity—a double-edged sword
    Mark J. Smyth
    Dale I. Godfrey
    Nature Immunology, 2000, 1 : 459 - 460
  • [42] Akt: a double-edged sword
    Meera Swami
    Nature Reviews Cancer, 2009, 9 : 76 - 77
  • [43] Ferroptosis: A double-edged sword
    Wang, Shengmei
    Guo, Qiuyan
    Zhou, Lili
    Xia, Xinhua
    CELL DEATH DISCOVERY, 2024, 10 (01)
  • [44] A Double-Edged Plastic Sword
    Rajeshwar, Krishnan
    ELECTROCHEMICAL SOCIETY INTERFACE, 2018, 27 (02): : 3 - 3
  • [45] AMLODIPINE DOUBLE-EDGED SWORD
    Rabah, Fatma
    Elnour, Ibtisam B.
    El-Naggari, Mohamed
    Al-Nabhani, Dana
    PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1657 - 1657
  • [46] CpG: The double-edged sword
    Paillard, F
    HUMAN GENE THERAPY, 1999, 10 (13) : 2089 - 2090
  • [47] Calcium: A double-edged sword
    Wetzel, Randall C.
    PEDIATRIC CRITICAL CARE MEDICINE, 2007, 8 (03) : 300 - 301
  • [48] Feedback: a double-edged sword
    不详
    IN PRACTICE, 2014, 36 (09) : 480 - 480
  • [49] Another double-edged sword
    不详
    IEEE SPECTRUM, 2003, 40 (11) : 11 - 11
  • [50] A double-edged sword for NSCLC?
    Alessia Errico
    Nature Reviews Clinical Oncology, 2014, 11 (2) : 66 - 66
12345